GTC is proud to present the Biomarker and Diagnostics Conference as part of the Biomarker Summit 2012.

Providing attendees a comprehensive study of using biomarkers as a diagnostic tool, this inaugural Conference focuses on this specific issue without sidetracking into other areas of contemporary research.
Diagnostics is a powerful tool in pharmaceutical development and the battle against disease. Providing attendees with one of the few opportunities to focus exclusively on diagnostics, attendees will benefit by gaining knowledge of today's latest developments by industry experts.
Beyond simply attending a conference, attendees will be part of the larger Biomarker Summit 2012 that also includes:

4th Oncology Biomarker Conference
6th Biomarker Development Conference
Biomarker Partnering and Deal-Making Conference

Limitless networking opportunities will be provided for attendees across all four Summit tracks. We look forward to welcoming you to the Biomarker Summit 2012!
The Conference features the following sessions:
Plenary Session
Regulatory & Policy Update
Keynote Speaker


Biomarker and Diagnostics
Next Generation Sequencing and Discovery of New Diagnostics (Dual Track)
Personalized Medicine for non-oncology uses (Dual Track)
Patient Selection & Stratification in the Design of Clinical Trials for New Diagnostics
Novel Approaches & Emerging Technologies for Diagnostics
Companion Diagnostics
•New DNA Companion Diagnostics
•New Protein Companion Diagnostics
Circulating/Body Fluid Biomarkers Developments
Novel methods for Prediction Algorithms